Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages.
This report contains market size and forecasts of OTC Cold and Cough Medicines in global, including the following market information:
Global OTC Cold and Cough Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global OTC Cold and Cough Medicines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five OTC Cold and Cough Medicines companies in 2021 (%)
The global OTC Cold and Cough Medicines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pellets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of OTC Cold and Cough Medicines include Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZeneca Plc., Pfizer Inc., Sun Pharmaceutical and Prestige Brands Holdings, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OTC Cold and Cough Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OTC Cold and Cough Medicines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global OTC Cold and Cough Medicines Market Segment Percentages, by Type, 2021 (%)
Pellets
Drops
Tablets
Capsules
Powders
Sprays
Global OTC Cold and Cough Medicines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global OTC Cold and Cough Medicines Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global OTC Cold and Cough Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global OTC Cold and Cough Medicines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC Cold and Cough Medicines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies OTC Cold and Cough Medicines revenues share in global market, 2021 (%)
Key companies OTC Cold and Cough Medicines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies OTC Cold and Cough Medicines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Johnson & Johnson
Reckitt Benckiser Group Plc.
Novartis AG
GlaxoSmithKline Plc.
AstraZeneca Plc.
Pfizer Inc.
Sun Pharmaceutical
Prestige Brands Holdings, Inc.
Procter & Gamble Co.